UTHR

United Therapeutics Corporation

Price

$515.11

return (12m)

66.58%

p/e

16.82

p/bv

3.45

DIVIDEND YIELD

0.00%

UTHR price

United Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment UTHR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-2.26%

3 months

-8.36%

1 year

66.58%

2 years

48.59%

5 years

143.65%

10 years

322.08%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals UTHR

Valuation

P/E

16.82

Sector -4.26

Industry -4.26

P/BV

3.45

Sector 2.11

Industry 2.11

P/Revenue (PSR)

6.99

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

3.05

Sector 1.25

Industry 1.25

P/Net Current Assets

8.28

Sector -5.47

Industry -5.47

P/Working Capital

7.67

Sector -1.10

Industry -1.10

EPS

30.49

Sector -1.94

Industry -1.94

BVPS

148.84

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

86.14%

Sector 38.90%

Industry 38.90%

EBITDA Margin

0.00%

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

0.00%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

44.44%

Sector -36.74%

Industry -36.74%

Net Profit Margins

41.56%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.11

Sector 0.03

Industry 0.03

Profitability

ROE

20.48%

Sector -61.50%

Industry -61.50%

ROA

18.16%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

5.73

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.89

Sector 0.43

Industry 0.43

Liabilities/Assets

0.11

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

13.35%

Sector -

Industry -

5Y Earnings CAGR

22.47%

Sector -

Industry -

FAIR VALUE OF United Therapeutics ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$515.11

Fair Value

$319.54

Upside Return potential.

-37.97%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals UTHR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
UTHR United Therapeutics Corporation	$515.11	68.68%	0.00%	16.82	3.45	20.48%	41.56%
JNJ Johnson & Johnson	$270.50	56.19%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$28.30	22.58%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$262.90	30.71%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$47.19	-12.22%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$153.10	86.45%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$166.27	6.54%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.57	50.14%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$77.52	-48.92%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$823.41	40.89%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$442.24	55.97%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$108.20	49.84%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$896.65	32.75%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$547.29	40.71%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$238.40	65.33%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.66	5.99%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$221.07	62.12%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

UTHR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT United Therapeutics

United Therapeutics Corporation

Average Investor10 user rating

4.0 (14 people)

United States

30 years

Founded: 1996

1999

Time since IPO - 27 years

920

Employees

United Therapeutics Corporation (United States) is listed on the Nasdaq and has a market capitalization of $22.05 billion, with shareholders equity totaling $6.40 billion.

The company employs approximately 920 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, United Therapeutics Corporation reported $3.15 billion in revenue, generating net income of $1.31 billion.

Key financial metrics include a P/E ratio of 16.82, a price-to-book (P/B) ratio of 3.45, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker UTHR.

Market cap

$22.05 billion

Net worth

$6.40 billion

$6,400,300,000.00

Assets

$7.22 billion

$7,220,100,000.00

Total Shares Outstanding

43.00 million

43,000,000

Average Daily Trading Volume

$520.28 Thousand

$520,279.74

Sector

Health Care

Industry

Biotechnology

UTHR

revenue by Business Segment United Therapeutics

Revenue by Region United Therapeutics

UTHR revenue and profits

Financial Results UTHR

DRAG THE FRAME TO SEE MORE DATA

UTHR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$896.65 31,86% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$238.40 61,79% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$270.50 57,62% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$262.90 30,39% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$153.10 89,20% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$166.27 6,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$28.30 22,92% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$896.65 31,86% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$238.40 61,79% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$270.50 57,62% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$262.90 30,39% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$153.10 89,20% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$166.27 6,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$28.30 22,92% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of United Therapeutics (UTHR) today?

A cotação de United Therapeutics (UTHR) hoje está em US$ 515.11, com uma variação de 66.58% em relação ao último ano. A cotação de United Therapeutics (UTHR) iniciou o ano negociando na casa dos US$ 487.25 e hoje está em US$ 515.11. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de United Therapeutics (UTHR) e dados de ações do Ibovespa e mercados internacionais.

Quando United Therapeutics (UTHR) paga dividendos?

United Therapeutics (UTHR) não distribuiu dividendos no último ano.

Is United Therapeutics (UTHR) a good investment?

Atualmente, United Therapeutics (UTHR) está cotada a US$ 515.11, com um P/L de 16.82, representando um desvio de 1,487% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 66.58 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 66.58%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy United Therapeutics (UTHR) stock?

Investir em ações de United Therapeutics (UTHR) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of United Therapeutics (UTHR) yield today?

A rentabilidade de United Therapeutics (UTHR) foi de -2.26% no último mês, 66.58% no último ano e 143.65% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de United Therapeutics (UTHR) hoje, o investimento total seria de US$ 51,511.00, com base na cotação atual de US$ 515.11.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 85,807.02
Em 5 anos: US$ 125,506.55
Em 10 anos: US$ 217,417.63

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

UTHR

United Therapeutics Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment UTHR

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING UTHR WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT United Therapeutics

United Therapeutics Corporation

United States

30 years

1999

920

PROFIT X PRICE UTHR

Financial Results UTHR

UTHR cash flow

Asset, Revenue and Profit Growth - UTHR

UTHR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions